Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × Congresses as Topic × Clear all

NCT06129851 2023-11-13

Relugolix in Combination With Radiation Therapy for Treating Patients With High Risk Prostate Cancer

Phase 2 Not yet recruiting

Prostatic Neoplasms

NCT00003832 2013-01-25

Broxuridine Plus Surgery in Treating Patients With Stage I or Stage II Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms